Stem Cells, Malaria, and the Genetics of Drug Response at Translational Medicine Symposium
The University of Pennsylvania's Institute for Translational Medicine and Therapeutics' 9th Annual International Symposium (ITMAT), Progress in Translational Science: Emerging Therapeutic Modalities, will be held on October 13-14. The symposium will feature outstanding speakers from the United States and abroad to address topics at the core of translational science. Speakers will include experts researching advances in stem cell biology, single cell metabolomics, and infectious diseases.
Date: Monday and Tuesday, October 13 - 14, 2013, starting at 8:30 am.
Location: Smilow Center for Translational Research, Rubenstein Auditorium and Lobby, 3400 Civic Center Blvd, Philadelphia, PA 19104
Additional Details
The symposium will feature presentations in six major areas:
- Challenges and Opportunities in Translational Research
- Stem Cell Therapeutics
- Movement in Malaria
- Focus on the Single Cell
- Variability in Drug Response
- Translational Immunology
Garret A. FitzGerald, MD, Director of ITMAT, will host the event. Speakers and talks include:
- Kenneth S. Zaret, PhD, Joseph Leidy Professor of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Discovering networks and diagnostics for pancreatic cancer progression
- Clifford J. Woolf, MB, BCh, PhD, Director, F.M. Kirby Neurobiology Center and Program in Neurobiology, Boston Children's Hospital, Professor of Neurology and Neurobiology, Harvard Medical School, Studying neurodegenerative disease in a dish
- Elaine Fuchs, PhD, Rebecca C. Lancefield Professor, HHMI, The Rockefeller University, Stem cells in homeostasis and cancer
- Beatrice H. Hahn, MD, Professor, Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Ape reservoirs of human malaria
- Jim Eberwine, PhD, Elmer Holmes Bobst Professor, Co-Director of the PENN Genome Frontiers Institute, Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, Single cell parables: Heterogeneity informs translational considerations
- Romina Goldszmid, PhD, Staff Scientist, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, NCI, NIH, The role of the microbiome in response to cancer therapy
- Paul Watkins, MD, Hamner-University of North Carolina Institute for Drug Safety Sciences, Why good drugs are sometimes bad for the liver – from man to mouse to computer
- Carl H. June, MD, Richard W. Vague Professor in Immunotherapy, Program Director of Translational Research, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Driving CARs for cancer: are we there yet?
For additional details and presentation times, visit the 2014 Full Agenda.
Provided by University of Pennsylvania School of Medicine